EUVIMEDEUVIMED entdecken
Crossref

QbD‐based stability‐indicating liquid chromatography (RP‐HPLC) method for the determination of flurbiprofen in cataplasm

Rathnakar Nathi iD, Leela Prasad Kowtharapu iD, Siva Krishna Muchakayala iD, Naresh Konduru iD

Biomedical Chromatography · 2023-04 · 37 (4)

DOI: 10.1002/bmc.5580 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 24.01.2023. Verfasst von Rathnakar Nathi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India. Hauptthemen laut MEDLINE: Flurbiprofen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A nonsteroidal drug called flurbiprofen (FBN) has analgesic, anti‐inflammatory and antipyretic activity. Currently the determination of FBN in cataplasm does not have any pharmacopeial method. However, the drug substance, tablet and ophthalmic solution formulations do have pharmacopeial methods. The development and validation of an accurate, precise and stability‐indicating analytical method for the determination of FBN in cataplasm formulations is reported. The gradient method was employed for the quantification of FBN in the presence of internal standards such as biphenyl. A nonpolar separation phase (C 18 , 250 × 4.6 mm, 5 μm Inertsil column; GL Sciences) was used. The optimal flow rate, column oven temperature, injection volume and detector wavelengths were 1.0 ml/min, 40°C, 20 μl and 245 nm, respectively. Mobile phase A was a mixture of water and glacial acetic acid (30:1 v/v) pH adjusted to 2.20 with glacial acetic acid or 1 m NaOH; mobile phase B was methanol (100%). The gradient elution program was [time (min)/% B]: 5/60, 20/70, 25/70, 30/60 and 40/60. The obtained RSDs for the precision and intermediate precision were 0.7 and 0.5%. The percentage recovery ranged from 99.2 to 100.4%. The linear regression coefficient >0.9996 indicates that all peak responses were linear with the concentration. The sample and standard solutions were stable for up to 24 h on the benchtop and in the refrigerator. The critical peaks were well separated from the generated peaks owing to forced degradation, including diluent and placebo peaks. The method validation data and quality by design‐based robustness study results indicate that the developed method is robust and fit for routine use in the quality control laboratory. The proposed method is specific, accurate and precise, and the quality by design utilized the first method for the determination of FBN in cataplasm formulations. Transdermal patches and gels have low extraction capacity and this method is applicable for quantification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlurbiprofenChromatography, High Pressure LiquidAcetic AcidDrug StabilityChromatography, Liquid

Stichwörter der Autor:innen

RP-HPLCbiphenylcataplasmsflurbiprofenquality by design

Substanzen

FlurbiprofenAcetic Acid

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Andhra University, Visakhapatnam, Andhra Pradesh, India.
  • Analytical Research and Development, STA Pharmaceutical Co. Ltd (Wuxi app Tec Company), Wuxi, China.
  • Analytical Research and Development, Catalent Pharma Solutions, Winchester, KY, USA.
  • Analytical Research and Development, Zhuhai Resproly Pharmaceutical Technology Co. Ltd, Zhuhai city, Guangdong Province, China.

ORCID-Profile: Rathnakar Nathi, Leela Prasad Kowtharapu, Siva Krishna Muchakayala, Naresh Konduru

Zitieren

APA

Nathi, R., Kowtharapu, L. P., Muchakayala, S. K., & Konduru, N. (2023). QbD‐based stability‐indicating liquid chromatography (RP‐HPLC) method for the determination of flurbiprofen in cataplasm. Biomedical Chromatography, 37(4). https://doi.org/10.1002/bmc.5580

Vancouver

Nathi R, Kowtharapu LP, Muchakayala SK, Konduru N. QbD‐based stability‐indicating liquid chromatography (RP‐HPLC) method for the determination of flurbiprofen in cataplasm. Biomedical Chromatography. 2023;37(4). doi:10.1002/bmc.5580

BibTeX
@article{Nathi2023,
  author = {Nathi, Rathnakar and Kowtharapu, Leela Prasad and Muchakayala, Siva Krishna and Konduru, Naresh},
  title = {QbD‐based stability‐indicating liquid chromatography (RP‐HPLC) method for the determination of flurbiprofen in cataplasm},
  journal = {Biomedical Chromatography},
  year = {2023},
  volume = {37},
  number = {4},
  doi = {10.1002/bmc.5580}
}
Kostenlos starten →